Your are eligible for Medicine on Earth
one year after your first
AMEDEO subscription (i.e. if you subscribed before
Sep 08, 2009 and if you have a medical profession. The Amedeo Team will inform you in time.
Direct access
Borislav DDimitrov
Alzano Lombardo
Bergamo
Lombardia
24022
Italy
Italy
email: bdd11@yahoo.com
Fields of Interest: clinical epidemiology, biostatistics, risk modeling, decision-making, quality of life, marketing surveys, rating indicators, environmental sustainability and energy efficiency, biothermodynamics, medical education
Curriculum Vitae
Borislav D Dimitrov was born in 1966 in Stara Zagora, Bulgaria.
He graduated at the Faculty of Medicine of the Thracian University in Stara Zagora in 1991 as M.D. and was awarded an advanced degree (M.Sc.) from the Faculty of Science and Engineering of The Victoria University of Manchester (England) in 1994. He was certified by the State board in 1998 as specialist in social medicine & health management (S.M.H.M.) after having completed his postgraduate training at the Medical University of Plovdiv (Bulgaria). In 1999, Dr Dimitrov sucessfully completed a 3-year full-time doctoral training in social medicine & health management (with emphasis on epidemiology and medical statistics) at the Department of Social Medicine and Health Management (Medical University of Plovdiv) with the thesis `Assessment of the dynamics in the spread of some malignant neoplasms in Bulgaria: nonlinear prognostic models` and the degree was awarded in 2006 (D.M./Ph.D.). In 1990, and during the following years, he was awarded and held the position of assistant professor in social medicine (public health, epidemiology, health management, medical statistics & medical informatics) as well as of registrar/specialist (Department of Patient Information, Computing & Network Support Services, Medical University Hospital - Plovdiv). He worked in various university, private and public clinical and administration settings as physician, lecturer, tutor, expert and consultant. He is fluent in Bulgarian (native), Russian, French, English and Italian languages.
In 2000 he joined the Mario Negri Institute for Pharmacological Research (Milano, Italy) as a visiting scientist and has been working as a senior scientist and consultant of clinical epidemiology and applied statistics at the Clinical Research Centre for Rare Diseases `Aldo e Cele Dacco` of the Institute in Ranica (BG). Currently, he lives in Alzano Lombardo, Bergamo, Italy.
Important publications
Dimitrov BD, Rachkova MI, Atanassova PA Cyclic patterns of incidence rate for skin malignant melanoma: association with
heliogeophysical activity. J Zhejiang Univ Sci B. 2008 Jun;9(6):489-95. Abstract
Atanassova PA, Chalakova NT, Dimitrov BD Major vascular events after transient ischaemic attack and minor ischaemic
stroke: post hoc modelling of incidence dynamics. Cerebrovasc Dis. 2008;25(3):225-33. Epub 2008 Jan 24. Abstract
Atanassova PA, Angelova E, Tzvetanov P, Semerdjieva M, Dimitrov BD Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional
matched case-control analysis in young patients. Arq Neuropsiquiatr. 2007 Mar;65(1):24-31. Abstract
Gallon L, Perico N, Dimitrov BD, Winoto J, Remuzzi G, Leventhal J, Gaspari F, Kaufman D Long-term renal allograft function on a tacrolimus-based, pred-free maintenance
immunosuppression comparing sirolimus vs. MMF. Am J Transplant. 2006 Jul;6(7):1617-23. Abstract
Parvanova AI, Trevisan R, Iliev IP, Dimitrov BD, Vedovato M, Tiengo A, Remuzzi G, Ruggenenti P Insulin resistance and microalbuminuria: a cross-sectional, case-control study of
158 patients with type 2 diabetes and different degrees of urinary albumin
excretion. Diabetes. 2006 May;55(5):1456-62. Abstract
Remuzzi G, Cravedi P, Perna A, Dimitrov BD, Turturro M, Locatelli G, Rigotti P, Baldan N, Beatini M, Valente U, Scalamogna M, Ruggenenti P Long-term outcome of renal transplantation from older donors. N Engl J Med. 2006 Jan 26;354(4):343-52. Abstract
Remuzzi G, Ruggenenti P, Perna A, Dimitrov BD, de Zeeuw D, Hille DA, Shahinfar S, Carides GW, Brenner BM Continuum of renoprotection with losartan at all stages of type 2 diabetic
nephropathy: a post hoc analysis of the RENAAL trial results. J Am Soc Nephrol. 2004 Dec;15(12):3117-25. Abstract
Parvanova A, Iliev I, Filipponi M, Dimitrov BD, Vedovato M, Tiengo A, Trevisan R, Remuzzi G, Ruggenenti P Insulin resistance and proliferative retinopathy: a cross-sectional, case-control
study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab. 2004 Sep;89(9):4371-6. Abstract
Remuzzi G, Lesti M, Gotti E, Ganeva M, Dimitrov BD, Ene-Iordache B, Gherardi G, Donati D, Salvadori M, Sandrini S, Valente U, Segoloni G, Mourad G, Federico S, Rigotti P, Sparacino V, Bosmans JL, Perico N, Ruggenenti P Mycophenolate mofetil versus azathioprine for prevention of acute rejection in
renal transplantation (MYSS): a randomised trial. Lancet. 2004 Aug 7-13;364(9433):503-12. Abstract
Perico N, Ruggenenti P, Gotti E, Gaspari F, Cattaneo D, Valente U, Salvadori M, Segoloni G, Donati D, Sandrini S, Ganeva M, Dimitrov BD, Remuzzi G In renal transplantation blood cyclosporine levels soon after surgery act as a
major determinant of rejection: insights from the MY.S.S. trial. Kidney Int. 2004 Mar;65(3):1084-90. Abstract
Dimitrov BD, Ruggenenti P, Stefanov R, Perna A, Remuzzi G Chronic nephropathies: individual risk for progression to end-stage renal failure
as predicted by an integrated probabilistic model. Nephron Clin Pract. 2003;95(2):c47-59. Abstract
Dimitrov BD, Perna A, Ruggenenti P, Remuzzi G Predicting end-stage renal disease: Bayesian perspective of information transfer
in the clinical decision-making process at the individual level. Kidney Int. 2003 May;63(5):1924-33. Abstract
Parvanova A, Iliev I, Dimitrov BD, Arnoldi F, Zaletel J, Remuzzi G, Ruggenenti P Hyperhomocysteinemia and increased risk of retinopathy: a cross-sectional,
case-control study in patients with type 2 diabetes. Diabetes Care. 2002 Dec;25(12):2361.
Plata R, Cornejo A, Arratia C, Anabaya A, Perna A, Dimitrov BD, Remuzzi G, Ruggenenti P Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a
prospective randomised trial. Lancet. 2002 Feb 23;359(9307):663-6. Abstract
Dimitrov BD Uncommon cancers are also important. Lancet Oncol. 2001 Feb;2(2):71-2.
Stefanov R, Dimitrov BD Viral-load kinetics in post-transplantation cytomegalovirus infections. Lancet. 2000 Nov 11;356(9242):1685-6.
Dimitrov BD Cyclic patterns of incidence variations for stomach cancer in the North-Western
region of England. Croat Med J. 2000 Jun;41(2):197-202. Abstract
Dimitrov BD Fibre and colorectal cancer. Lancet. 1996 Oct 5;348(9032):958-9.
Dimitrov BD The storage of energy as a cause of malignant transformation: a 7-phase model of
carcinogenesis. Med Hypotheses. 1993 Nov;41(5):425-33. Abstract
Dimitrov BD Heliophysical activity and incidence variations of skin malignant melanoma in
Czechoslovakia: a regional study. Int J Biometeorol. 1993 May;37(2):68-71. Abstract